Estrella Immunopharma annual working capital
2021
2022
2022
2023
2024
2024
2025
Estrella Immunopharma Working Capital Growth & History (ESLA)
Estrella Immunopharma's working capital was −$11.9M for fiscal 2025.
View full Estrella Immunopharma company overviewEstrella Immunopharma annual working capital history
| Fiscal year | Period ended | Working capital | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$11.9M | −$10.5M | — |
| 2024 · Dec 31 | 2024-12-31 | −$1.4M | — | — |
| 2024 · Jun 30 | 2024-06-30 | $4.3M | $11.3M | — |
| 2023 | 2023-06-30 | −$7.0M | −$11.0M | — |
| 2022 | 2022-12-31 | −$1.0M | −$1.6M | — |
| 2022 | 2022-06-30 | $4.0M | — | — |
| 2021 | 2021-12-31 | $542,880 | — | — |
Estrella Immunopharma quarterly working capital
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q4.23
Q2.24
Q3.24
Q4.24
Q1.25
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Working capital | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$7.4M | $163,335 | — |
| Q1 2026 | 2026-03-31 | −$6.8M | −$3.4M | — |
| Q4 2025 | 2025-12-31 | −$11.9M | −$10.5M | — |
| Q3 2025 | 2025-09-30 | −$11.3M | −$10.6M | — |
| Q2 2025 | 2025-06-30 | −$7.6M | −$11.9M | — |
| Q1 2025 · Mar 31 | 2025-03-31 | −$3.3M | −$11.8M | — |
| Q4 2024 · Dec 31 | 2024-12-31 | −$1.4M | −$10.4M | — |
| Q1 2025 · Sep 30 | 2024-09-30 | −$753,714 | — | — |
| Q4 2024 · Jun 30 | 2024-06-30 | $4.3M | $11.3M | — |
| Q3 2024 | 2024-03-31 | $8.5M | — | — |
| Q2 2024 | 2023-12-31 | $9.0M | $10.1M | — |
| Q4 2023 | 2023-06-30 | −$7.0M | −$7.0M | — |
| Q4 2022 | 2022-12-31 | −$1.0M | −$1.6M | — |
| Q3 2022 | 2022-09-30 | −$575,002 | −$1.3M | — |
| Q2 2022 | 2022-06-30 | −$25,825 | — | — |
| Q1 2022 | 2022-03-31 | $397,940 | — | — |
| Q4 2021 | 2021-12-31 | $542,880 | — | — |
| Q3 2021 | 2021-09-30 | $679,534 | — | — |
Estrella Immunopharma working capital trends
Between the periods ended 2021-12-31 and 2025-12-31, Estrella Immunopharma's working capital decreased from $542,880 to −$11.9M, a change of −$12.4M. The latest reported quarter, Q2 2026, shows −$7.4M.
About the metric
What working capital means
Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.
Calculation and source
How working capital is calculated
TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Estrella Immunopharma source filings ↗